IPL344 IV

· Immunity Pharma Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IPL344 IV, covering 2025-01-10 to 2025-01-10. Get the full timeline:

Most recent: Clinical Trial Update: A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV [Phase 2]